Related references
Note: Only part of the references are listed.Up-regulation of the PI3K/AKT and RHO/RAC/PAK signalling pathways in CHK1 inhibitor resistant E?-Myc lymphoma cells
Jill E. Hunter et al.
BIOCHEMICAL JOURNAL (2022)
Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway
Jill E. Hunter et al.
BIOCHEMICAL JOURNAL (2022)
Claspin haploinsufficiency leads to defects in fertility, hyperplasia and an increased oncogenic potential
Suzanne Madgwick et al.
BIOCHEMICAL JOURNAL (2022)
Temporal modulation of the NF-κB ReIA network in response to different types of DNA damage
Amy E. Campbell et al.
BIOCHEMICAL JOURNAL (2021)
Synergistic targeting of CHK1 and mTOR in MYC-driven tumors
Xiaoxue Song et al.
CARCINOGENESIS (2021)
Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics
Dominic P. Byrne et al.
BIOCHEMICAL JOURNAL (2020)
Claspin - checkpoint adaptor and DNA replication factor
Veronique A. J. Smits et al.
FEBS JOURNAL (2019)
DNA Binding and Phosphorylation Regulate the Core Structure of the NF-B p50 Transcription Factor
Matthias Vonderach et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Evaluation of Parameters for Confident Phosphorylation Site Localization Using an Orbitrap Fusion Tribrid Mass Spectrometer
Samantha Ferries et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
DNA damage response inhibitors: Mechanisms and potential applications in cancer therapy
Laura Carrassa et al.
CANCER TREATMENT REVIEWS (2017)
The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma
J. E. Hunter et al.
ONCOGENE (2016)
The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eμ-MYC driven B-cell lymphoma
Mike I. Walton et al.
ONCOTARGET (2016)
A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-κB-dependent liver regeneration and cancer
A. Moles et al.
ONCOGENE (2016)
Dynamic phosphorylation of RelA on Ser42 and Ser45 in response to TNFα stimulation regulates DNA binding and transcription
Francesco Lanucara et al.
OPEN BIOLOGY (2016)
The Regulation of NF-κB Subunits by Phosphorylation
Frank Christian et al.
CELLS (2016)
Evaluating Multiplexed Quantitative Phosphopeptide Analysis on a Hybrid Quadrupole Mass Filter/Linear Ion Trap/Orbitrap Mass Spectrometer
Brian K. Erickson et al.
ANALYTICAL CHEMISTRY (2015)
Myc induced replicative stress response: How to cope with it and exploit it
Sara Rohban et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors
Adil I. Daud et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress
Apolinar Maya-Mendoza et al.
MOLECULAR ONCOLOGY (2015)
Using body temperature, food and water consumption as biomarkers of disease progression in mice with Eμ-myc lymphoma
J. E. Hunter et al.
BRITISH JOURNAL OF CANCER (2014)
Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic Strategies
Christine M. Lovly et al.
CLINICAL CANCER RESEARCH (2014)
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Young Hee Choi et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Synthesis and Structure-Activity Relationship Studies of N-Benzyl-2-phenylpyrimidin-4-amine Derivatives as Potent USP1/UAF1 Deubiquitinase Inhibitors with Anticancer Activity against Nonsmall Cell Lung Cancer
Thomas S. Dexheimer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Chronic inflammation induces telomere dysfunction and accelerates ageing in mice
Diana Jurk et al.
NATURE COMMUNICATIONS (2014)
MYC and the Control of DNA Replication
David Dominguez-Sola et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
c-MYC-Induced Genomic Instability
Alexandra Kuzyk et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
The Proteomics Identifications (PRIDE) database and associated tools: status in 2013
Juan Antonio Vizcaino et al.
NUCLEIC ACIDS RESEARCH (2013)
CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
Mike I. Walton et al.
CLINICAL CANCER RESEARCH (2012)
Mechanisms of replication fork protection: a safeguard for genome stability
Alessia Errico et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
P. T. Ferrao et al.
ONCOGENE (2012)
Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance
Stefano Campaner et al.
CELL DIVISION (2012)
The diverse and complex roles of NF-κB subunits in cancer
Neil D. Perkins
NATURE REVIEWS CANCER (2012)
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations
Hua Jing et al.
GENES & DEVELOPMENT (2011)
Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity
Yuchen Chien et al.
GENES & DEVELOPMENT (2011)
Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening
Timothy J. Guzi et al.
MOLECULAR CANCER THERAPEUTICS (2011)
MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics
Lily Ting et al.
NATURE METHODS (2011)
Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors
Matilde Murga et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
IKK and NF-κB-mediated regulation of Claspin impacts on ATR checkpoint function
Niall Steven Kenneth et al.
EMBO JOURNAL (2010)
Specification of the NF-κB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKKε
Rita Moreno et al.
NUCLEIC ACIDS RESEARCH (2010)
Regulation of the ReIA (p65) transactivation domain
John M. O'Shea et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Sequential and synergistic modification of human RPA stimulates chromosomal DNA repair
Rachel W. Anantha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
RPA2 is a direct downstream target for ATR to regulate the S-phase checkpoint
Erin Olson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway
N. D. Perkins
ONCOGENE (2006)
NF-κB and IKK as therapeutic targets in cancer
HJ Kim et al.
CELL DEATH AND DIFFERENTIATION (2006)
Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-κB transactivation
KJ Campbell et al.
CANCER RESEARCH (2006)
DNA damage induced hyperphosphorylation of replication protein A. 1. Identification of novel sites of phosphorylation in response to DNA damage
JE Nuss et al.
BIOCHEMISTRY (2005)
Regulation of NF-κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
S Rocha et al.
EMBO JOURNAL (2005)
Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation
P Viatour et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB
KJ Campbell et al.
MOLECULAR CELL (2004)
Phosphatidyl inositol 3-kinase-like serine/threonine protein kinases (PIKKs) are required for DNA damage-induced phosphorylation of the 32 kDa subunit of replication protein A at threonine 21
WD Block et al.
NUCLEIC ACIDS RESEARCH (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
p53- and Mdm2-independent repression of NF-κB transactivation by the ARF tumor suppressor
S Rocha et al.
MOLECULAR CELL (2003)
Share Paper
